Novel diketopiperazine derivatives as oxytocin receptor antagonists
Compounds of formula (I) wherein R 1 is 2-indanyl, R 2 is 1-methylpropyl, R 3 is a group selected from 2, 6-dimethyl-3-pyridyl or 4,6-dimethyl-3-pyridyl, R 4 represents methyl and R 5 represents hydrogen or methyl or, R 4 and R 5 together with the nitrogen atom to which they are attached represent m...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
11.09.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Compounds of formula (I)
wherein R 1 is 2-indanyl, R 2 is 1-methylpropyl, R 3 is a group selected from 2, 6-dimethyl-3-pyridyl or 4,6-dimethyl-3-pyridyl, R 4 represents methyl and R 5 represents hydrogen or methyl or, R 4 and R 5 together with the nitrogen atom to which they are attached represent morpholino and pharmaceutically acceptable derivatives thereof are described, as are processes for their preparation, pharmaceutical compositions containing them and their use in medicine, particularly their use as oxytocin antagonists. |
---|---|
AbstractList | Compounds of formula (I)
wherein R 1 is 2-indanyl, R 2 is 1-methylpropyl, R 3 is a group selected from 2, 6-dimethyl-3-pyridyl or 4,6-dimethyl-3-pyridyl, R 4 represents methyl and R 5 represents hydrogen or methyl or, R 4 and R 5 together with the nitrogen atom to which they are attached represent morpholino and pharmaceutically acceptable derivatives thereof are described, as are processes for their preparation, pharmaceutical compositions containing them and their use in medicine, particularly their use as oxytocin antagonists. |
Author | LIDDLE, JOHN HICKEY, DEIRDRE MARY BERNADETTE MASON, ANDREW MCMURTRIE BORTHWICK, ALAN DAVID |
Author_xml | – fullname: BORTHWICK, ALAN DAVID – fullname: LIDDLE, JOHN – fullname: MASON, ANDREW MCMURTRIE – fullname: HICKEY, DEIRDRE MARY BERNADETTE |
BookMark | eNqNyj0KwkAQBtAttPDvDnMBq4RgnaBoYxWwDEPyKYNhZtkdFvX0Nh7A6jVvHRZqilXorlYw0yRPuEWJSPwRBU1IUtilIBNnstfbbRSlhBHRLRGr88NUsudtWN55ztj93AQ6HfvuvEe0ATnyCIUP_e1S1Ye6adq2-qN8AczTNZE |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | TWI348466BB |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_TWI348466BB3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:54:32 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Chinese English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_TWI348466BB3 |
Notes | Application Number: TW200594120517 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110911&DB=EPODOC&CC=TW&NR=I348466B |
ParticipantIDs | epo_espacenet_TWI348466BB |
PublicationCentury | 2000 |
PublicationDate | 20110911 |
PublicationDateYYYYMMDD | 2011-09-11 |
PublicationDate_xml | – month: 09 year: 2011 text: 20110911 day: 11 |
PublicationDecade | 2010 |
PublicationYear | 2011 |
RelatedCompanies | GLAXO GROUP LIMITED |
RelatedCompanies_xml | – name: GLAXO GROUP LIMITED |
Score | 2.9298754 |
Snippet | Compounds of formula (I)
wherein R 1 is 2-indanyl, R 2 is 1-methylpropyl, R 3 is a group selected from 2, 6-dimethyl-3-pyridyl or 4,6-dimethyl-3-pyridyl, R 4... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Novel diketopiperazine derivatives as oxytocin receptor antagonists |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110911&DB=EPODOC&locale=&CC=TW&NR=I348466B |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLbGQMANBojxUg6ot4r1ufVQIfUxDaR1EypstylZMjaB2mot4_HrccMKXOAWJZLlWLGdfIm_AFwyrs0s1rFV0elw1eRtXaXcQMfTWzazqDAdiUP2I7t3b96OrXEN5lUtjOQJfZXkiOhRU_T3Qsbr7AfECuTbyvyKLbArve7GbqDwCu7D9KcpgeeGw0Ew8BXfd-OREt25N4aJmdb2NmCz3ESXLPvhg1fWpGS_E0p3D7aGKCsp9qH2MW_Ajl_9u9aA7f76uhuba8_LD8CP0pV4JnzxJIo0W2RiKXmhCccVtJLk3TmhOUnf3gs0d0IwkIkMz9MELUcf05IfNz8E0g1jv6eiNpPviU_iUaW2ZxxBPUkTcQxEiLJ4VafOlBrm1HSYxXTB7faMaoK1hN2E5p9iTv4ZO4XdL8DUUTXtDOrF8kWcY8Yt2IU01icAHYkT |
link.rule.ids | 230,309,786,891,25594,76904 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4gGvGmqBGfezC9NdIn9NCYtIWAQiGmCjfSZRchmrahFR-_3ulK1YveNrvJZHayM5P5dudbgEvKlJlBm6bMm00m66yhyiHT0PHUukmNkOuWwCH7vtm512_GxrgE86IXRvCEvgpyRPSoKfp7JuJ18gNieeJtZXpFFzgVX7cD25NYAfdh-lMkz7Fbw4E3cCXXtYOR5N_ZXU3HTGs6G7DZwIIwZ9lvPTh5T0ryO6G0d2FriLKibA9KH_MqVNzi37UqbPfX1904XHteug-uH6_4M2GLJ57FySLhS8ELTRieoJUg705JmJL47T1Dc0cEAxlPsJ4maLnwMc75cdMDIO1W4HZk1GbyvfFJMCrUdrRDKEdxxI-AcJ43r6qhNQ01fapb1KAqZ2ZjFiqc1rlZg9qfYo7_WbuASifo9ya9rn97Ajtf4KklK8oplLPlCz_D7JvRc2G4T4-Di_4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Novel+diketopiperazine+derivatives+as+oxytocin+receptor+antagonists&rft.inventor=BORTHWICK%2C+ALAN+DAVID&rft.inventor=LIDDLE%2C+JOHN&rft.inventor=MASON%2C+ANDREW+MCMURTRIE&rft.inventor=HICKEY%2C+DEIRDRE+MARY+BERNADETTE&rft.date=2011-09-11&rft.externalDBID=B&rft.externalDocID=TWI348466BB |